SOUTH AFRICA —Pharmaceutical giant Johnson & Johnson (J&J), headquartered in the United States, is now under scrutiny in South Africa for purportedly imposing “excessive” pricing on a vital tuberculosis medication,…
Read MoreTag: Johnson & Johnson
South Africa’s COVID-19 vaccine contracts reveal disparities and risk assumptions
SOUTH AFRICA — An analysis of South Africa’s COVID-19 vaccine contracts has shed light on pricing disparities and risk assumptions made by pharmaceutical companies. According to the Health Justice Initiative…
Read MoreNeuromedicine startup Rapport Therapeutics secures US$150 million in Series B funding to propel clinical progress
USA — Rapport Therapeutics, a cutting-edge neuromedicine startup backed by Johnson & Johnson, has announced the successful completion of a remarkable US$150 million series B funding round. Having launched earlier…
Read MoreBiosense Webster’s FDA approval paves the way for zero fluoroscopy workflow
USA —Biosense Webster, a distinguished entity within Johnson & Johnson MedTech has unveiled its triumphant achievement of gaining U.S. Food and Drug Administration (FDA) approval for a zero-fluoroscopy workflow for…
Read MoreFDA greenlights Johnson & Johnson’s Akeega for BRCA-positive prostate cancer
USA — Johnson & Johnson has secured the coveted FDA approval for Akeega, a pioneering combination tablet poised to redefine the landscape of metastatic castration-resistant prostate cancer (mCRPC) treatment in…
Read MoreJohnson & Johnson names the new Managing Director of its medical device business in India
INDIA – Johnson & Johnson Private Limited has selected Anuj Virmani as the new Managing Director for its medical device business in India. Anuj Virmani has been tapped as the…
Read MoreJohnson & Johnson foresees robust growth in 2023, bolstered by medical advancements and pharmaceutical portfolio
USA —Johnson & Johnson, a prominent healthcare conglomerate, is brimming with optimism as it anticipates a year of strong growth, surpassing profit estimates. The resurgence of joint replacement surgeries and…
Read MoreJohnson & Johnson fights back to challenge the prescription price battle, claiming constitutional violations
USA — As the battle intensifies over a new law aimed at lowering prescription drug prices, Johnson & Johnson’s pharmaceutical unit, Janssen Pharmaceuticals, has entered the fray, arguing that the…
Read MoreDoctors Without Borders Criticizes Johnson & Johnson’s TB drug agreement
SWITZERLAND —Efforts to expand access to Johnson & Johnson’s tuberculosis (TB) drug, Sirturo (bedaquiline), have faced criticism from Médecins Sans Frontières (MSF), also known as Doctors Without Borders. The deal…
Read MoreTB drug agreement fails to address high-burden countries in Eastern Europe and Central Asia, raising concerns
SWITZERLAND —A recent licensing agreement between pharmaceutical giant Johnson & Johnson (J&J) and the Stop TB Partnership has sparked debate over its effectiveness in expanding access to life-saving tuberculosis (TB)…
Read More